Establishment of nutritional therapy for prevention of sarcopenia in patients with autoimmune and rheumatic diseases
- Conditions
- Autoimmune and rheumatic diseases
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 56
(1) Patients who have given their free and voluntary written consent to participate in this study after receiving full explanation and with full understanding (2) Patients aged 16 years or older, regardless of gender (3) Patients who have been diagnosed with rheumatoid/ collagen diseases and related diseases by the time of enrollment (4) Patients who were admitted to our department.
(1) Patients requiring urgent treatment (2) Patients undergoing treatment for malignant diseases (3) Patients with severe renal disease (4) Patients with severe hepatic disorder (5) Other patients who are judged to be inappropriate by the physician
Study & Design
- Study Type
- Interventional
- Study Design
- single assignment
- Primary Outcome Measures
Name Time Method - Difference in SMI change at 4 weeks between treatment groups
- Secondary Outcome Measures
Name Time Method SMI value at 4 weeks 4 weeks The association will be evaluated by a linear regression model with the SMI value at 4 weeks as the objective variable and risk factors (age, BMI, and gender) as explanatory variables.